Alternate-day antipsychotic dosing for schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial looks at whether taking an antipsychotic every other day can keep symptoms controlled in adults with schizophrenia or another psychotic disorder. It may help some people avoid daily dosing, but it requires specific medication stability and screening checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have a diagnosis of schizophrenia spectrum or another psychotic disorder
- Speak and understand English well enough for study discussions and paperwork
- Be able to sign consent in writing after understanding study details
- For at least 3 months, your symptoms must be stable while taking one of these by mouth: risperidone, olanzapine, or paliperidone at a specific dose range
- You must be taking your current antipsychotic consistently (adherence), and have a negative pregnancy test if you can become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more intensive medication approach for schizophrenia (or related conditions) helps people who didn’t improve on their first tried medicine. Participants will usually switch medicines and be compared against “treatment as usual.”
This trial tests whether taking clozapine once a day (instead of twice a day) works safely for people with schizophrenia. It may help by simplifying your dosing schedule while closely monitoring your wellbeing.
This study looks at whether people with schizophrenia who are currently stable on oral antipsychotics can switch back to daily pills from a long-acting injection (paliperidone palmitate). The goal is to see if symptoms stay controlled and daily functioning improves after the switch.
This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.
This study compares whether slowly reducing antipsychotic medication is as effective as staying on the current dose for people with schizophrenia or related disorders. It uses a personalized approach to help you and your doctor decide which option may work best for you.
This is an observational (non-intervention) study that follows adults with schizophrenia who are taking specific “atypical” antipsychotic medicines long-term. Researchers want to learn about patients’ experiences and outcomes while on these treatments.
Hear when a new Schizophrenia and Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.